Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center
Hsin-Hsien Yu,1,2 Yutaka Yonemura,3–5 Mao-Chih Hsieh,1,2 Akiyoshi Mizumoto,4 Satoshi Wakama,3 Chang-Yun Lu1,2 1Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 2Division of General Surgery, Department of Surgery, Wan Fang Hospital,...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-10-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-fo-peer-reviewed-article-CMAR |
| _version_ | 1818553132780617728 |
|---|---|
| author | Yu HH Yonemura Y Hsieh MC Mizumoto A Wakama S Lu CY |
| author_facet | Yu HH Yonemura Y Hsieh MC Mizumoto A Wakama S Lu CY |
| author_sort | Yu HH |
| collection | DOAJ |
| description | Hsin-Hsien Yu,1,2 Yutaka Yonemura,3–5 Mao-Chih Hsieh,1,2 Akiyoshi Mizumoto,4 Satoshi Wakama,3 Chang-Yun Lu1,2 1Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 2Division of General Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; 3Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan; 4Department of Surgery, Kusatsu General Hospital, Kusatsu, Shiga, Japan; 5Nonprofit Organization to Support Peritoneal Surface Malignancy Treatment, Kyoto, Osaka, Japan Background: Goblet cell carcinomas (GCCs) of the appendix are rare and aggressive malignancies with early peritoneal dissemination. The aim of the present article is to describe our experience in the management of GCCs with peritoneal carcinomatosis (PC) through cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) and to determine the impact of multiple clinical characteristics on the prognosis.Methods: From a prospectively maintained database of patients receiving CRS and HIPEC for peritoneal surface malignancy, the data of 15 patients with GCC and PC were collected. Neoadjuvant laparoscopic HIPEC was performed if indicated. CRS and HIPEC with mitomycin-C or 5-fluorouracil plus oxaliplatin were performed. Adjuvant chemotherapy was also arranged if suitable for the patient’s condition.Results: Nine males and six females with a mean age of 52.4 years were enrolled. The estimated median survival after the diagnosis of GCC with PC and after definitive CRS–HIPEC was 28 and 17 months, respectively. The 1-, 2-, 3-, 4-year survival rates were 86%, 69%, 57%, and 24%, respectively. Log-rank test revealed that the significant independent risk factors for more favorable outcomes were age >50 years, peritoneal cancer index (PCI) <27, postoperative PCI <20, administration of HIPEC, and adjuvant chemotherapy. Multivariate analyses confirmed that administration of HIPEC played a crucial role in providing prognostic benefit.Conclusion: The management of GCC with PC remains challenging. We recommend CRS and HIPEC, followed by adjuvant systemic chemotherapy, as a promising strategy to improve survival, especially in selected patients with low PCI and possibility to achieve complete cytoreduction. Keywords: cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, appendiceal goblet cell carcinomas, peritoneal carcinomatosis |
| first_indexed | 2024-12-12T09:21:58Z |
| format | Article |
| id | doaj.art-18eb2dcef31f46caa13f5f45efd07160 |
| institution | Directory Open Access Journal |
| issn | 1179-1322 |
| language | English |
| last_indexed | 2024-12-12T09:21:58Z |
| publishDate | 2017-10-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj.art-18eb2dcef31f46caa13f5f45efd071602022-12-22T00:29:10ZengDove Medical PressCancer Management and Research1179-13222017-10-01Volume 951352335237Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized centerYu HHYonemura YHsieh MCMizumoto AWakama SLu CYHsin-Hsien Yu,1,2 Yutaka Yonemura,3–5 Mao-Chih Hsieh,1,2 Akiyoshi Mizumoto,4 Satoshi Wakama,3 Chang-Yun Lu1,2 1Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 2Division of General Surgery, Department of Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; 3Peritoneal Dissemination Center, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan; 4Department of Surgery, Kusatsu General Hospital, Kusatsu, Shiga, Japan; 5Nonprofit Organization to Support Peritoneal Surface Malignancy Treatment, Kyoto, Osaka, Japan Background: Goblet cell carcinomas (GCCs) of the appendix are rare and aggressive malignancies with early peritoneal dissemination. The aim of the present article is to describe our experience in the management of GCCs with peritoneal carcinomatosis (PC) through cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) and to determine the impact of multiple clinical characteristics on the prognosis.Methods: From a prospectively maintained database of patients receiving CRS and HIPEC for peritoneal surface malignancy, the data of 15 patients with GCC and PC were collected. Neoadjuvant laparoscopic HIPEC was performed if indicated. CRS and HIPEC with mitomycin-C or 5-fluorouracil plus oxaliplatin were performed. Adjuvant chemotherapy was also arranged if suitable for the patient’s condition.Results: Nine males and six females with a mean age of 52.4 years were enrolled. The estimated median survival after the diagnosis of GCC with PC and after definitive CRS–HIPEC was 28 and 17 months, respectively. The 1-, 2-, 3-, 4-year survival rates were 86%, 69%, 57%, and 24%, respectively. Log-rank test revealed that the significant independent risk factors for more favorable outcomes were age >50 years, peritoneal cancer index (PCI) <27, postoperative PCI <20, administration of HIPEC, and adjuvant chemotherapy. Multivariate analyses confirmed that administration of HIPEC played a crucial role in providing prognostic benefit.Conclusion: The management of GCC with PC remains challenging. We recommend CRS and HIPEC, followed by adjuvant systemic chemotherapy, as a promising strategy to improve survival, especially in selected patients with low PCI and possibility to achieve complete cytoreduction. Keywords: cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, appendiceal goblet cell carcinomas, peritoneal carcinomatosishttps://www.dovepress.com/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-fo-peer-reviewed-article-CMARCytoreductive surgeryhyperthermic intraperitoneal chemotherapyappendiceal goblet cell carcinomas |
| spellingShingle | Yu HH Yonemura Y Hsieh MC Mizumoto A Wakama S Lu CY Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center Cancer Management and Research Cytoreductive surgery hyperthermic intraperitoneal chemotherapy appendiceal goblet cell carcinomas |
| title | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| title_full | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| title_fullStr | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| title_full_unstemmed | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| title_short | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| title_sort | cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis results from a single specialized center |
| topic | Cytoreductive surgery hyperthermic intraperitoneal chemotherapy appendiceal goblet cell carcinomas |
| url | https://www.dovepress.com/cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-fo-peer-reviewed-article-CMAR |
| work_keys_str_mv | AT yuhh cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter AT yonemuray cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter AT hsiehmc cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter AT mizumotoa cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter AT wakamas cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter AT lucy cytoreductivesurgeryandhyperthermicintraperitonealchemotherapyforappendicealgobletcellcarcinomaswithperitonealcarcinomatosisresultsfromasinglespecializedcenter |